Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B

Jun 18, 2025 - 21:50
 0
Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B